Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT05005767
Other study ID # 2D
Secondary ID
Status Active, not recruiting
Phase Phase 2
First received
Last updated
Start date April 1, 2021
Est. completion date March 2022

Study information

Verified date August 2021
Source Tanta University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will evaluate the effect of the subgingival application of Frankincense extract gel as an adjunct to scaling and root planning (SRP) in chronic periodontitis.


Description:

: twenty patients will be randomly selected and equally divided into Group I: will receive SRP only, group II: will receive SRP and Frankincense extract the gel. Subgingival application of Frankincense extract gel will be performed following initial SRP )day 1) and at 7, and 14 days. Clinical measurements included pocket depth (PD), bleeding on probing (BOP), and clinical attachment level (CAL). Real-time PCR was carried out to determine the effect of the treatment on Porphyromonas gingivalis (Pg). Clinical measurements and Plaque samples for PCR were recorded at baseline (before treatment), one, and three months after treatment.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 20
Est. completion date March 2022
Est. primary completion date November 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria: - systemically healthy patients were selected - patients who had not received any medications for the previous six months that may interfere with periodontal tissue health or healing. - Patients should demonstrate their ability to maintain good oral hygiene Exclusion Criteria: - Smokers and pregnant patients. - Medically compromised patients and systemic conditions precluding periodontal surgery.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
scaling and root planing
will receive scaling and root planing only
Frankincense extract gel natural herbal product
will receive Scaling and root planing then. Subgingival application of Frankincense extract gel

Locations

Country Name City State
Egypt Doaa Ahmed yousef bayoumi Tanta Gharbiya

Sponsors (1)

Lead Sponsor Collaborator
Tanta University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary probing pocket depth probing pocket depth will be recorded at baseline, at site that will be treated baseline
Primary probing pocket depth probing pocket depth will be recorded at 1 month at the site to be treated 1 month
Primary probing pocket depth probing pocket depth will be recorded at 3 month at the site to be treated 3 month
Primary clinical attachment level clinical attachment level will be recorded at baseline, baseline
Primary clinical attachment level clinical attachment level will be recorded at , 1 month at the site to be treated 1 month
Primary clinical attachment level clinical attachment level will be recorded at 3 months at the site to be treated 3 month
Primary bleeding on probing bleeding on probingwill be recorded at baseline, at the site to be treated baseline
Primary bleeding on probing bleeding on probingwill be recorded at 1, month at the site to be treated 1 month
Primary bleeding on probing bleeding on probingwill be recorded at 3 months at the site to be treated 3 month
Primary PCR for Porphyromonas gingivalis count PCR for Porphyromonas gingivalis count be recorded at baseline, at the site to be treated baseline
Primary PCR for Porphyromonas gingivalis count PCR for Porphyromonas gingivalis count be recorded at 1, and month at the site to be treated 1 month
Primary PCR for Porphyromonas gingivalis count PCR for Porphyromonas gingivalis count be recorded at 3 months at the site to be treated 3 month
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06400069 - Role of NLRP6 in Chronic Periodontitis
Completed NCT05231096 - Comparison of the Effect of Gingival Massage of Aloe-vera Gel and Sidr Honey on Chronic Periodontitis N/A
Completed NCT03203746 - Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis Phase 1/Phase 2
Active, not recruiting NCT03354338 - Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy Phase 2
Completed NCT02516111 - Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment Phase 2/Phase 3
Completed NCT02174146 - Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy N/A
Terminated NCT02568163 - Influence of Stress on Non Surgical Periodontal Treatment N/A
Completed NCT02430519 - Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects N/A
Completed NCT01438333 - Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection N/A
Completed NCT01233765 - Analysis of Neutrophil Response in Chronic Periodontitis N/A
Completed NCT02218515 - Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft Phase 4
Completed NCT02197260 - Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing Phase 4
Not yet recruiting NCT03270280 - Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis Phase 2
Not yet recruiting NCT04026828 - Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods
Completed NCT04643288 - Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects N/A
Completed NCT04697199 - The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis Phase 1
Completed NCT03039244 - Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers N/A
Completed NCT02851823 - Combined Use of Er:YAG and Nd:YAG Laser N/A
Completed NCT02898675 - Advantages of Autologous Platelet-Rich Fibrin Membrane on Growth Factor Levels and Periodontal Healing N/A
Completed NCT02518152 - Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis Phase 2/Phase 3